Fast Market Research

New Market Study, "Phosphagenics Limited - Product Pipeline Review - 2013", Has Been Published

Recently published research from Global Markets Direct, "Phosphagenics Limited - Product Pipeline Review - 2013", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 10/24/2013 -- Global Market Direct's pharmaceuticals report, "Phosphagenics Limited - Product Pipeline Review - 2013" provides data on the Phosphagenics Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Phosphagenics Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Phosphagenics Limited and industry-specific third party sources, put together by Global Markets Direct's team.


View Full Report Details and Table of Contents

- Phosphagenics Limited - Brief Phosphagenics Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Phosphagenics Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Phosphagenics Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Phosphagenics Limited's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Phosphagenics Limited's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Phosphagenics Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Phosphagenics Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Phosphagenics Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Phosphagenics Limited and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Phosphagenics Limited - Product Pipeline Review - 2012
- Alchemia Limited - Product Pipeline Review - 2013
- Progen Pharmaceuticals Limited - Product Pipeline Review - 2013
- CSL Limited - Product Pipeline Review - 2013
- Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2013
- Lupin Limited - Product Pipeline Review - 2013
- Daiichi Sankyo Company, Limited - Product Pipeline Review - 2013
- Pharmaxis Limited - Product Pipeline Review - 2013
- Takeda Pharmaceutical Company Limited - Product Pipeline Review - 2013
- Hutchison MediPharma Limited - Product Pipeline Review - 2013